Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

607 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results.
Park HS, Park SJ, Kim JY, Kim S, Ryu J, Sohn J, Park S, Kim GM, Hwang IS, Choi JR, Kim SI. Park HS, et al. Among authors: kim jy, kim s, kim gm, kim si. Ann Surg Treat Res. 2017 May;92(5):331-339. doi: 10.4174/astr.2017.92.5.331. Epub 2017 Apr 27. Ann Surg Treat Res. 2017. PMID: 28480178 Free PMC article.
Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy.
Kim CG, Sohn J, Chon H, Kim JH, Heo SJ, Cho H, Kim IJ, Kim SI, Park S, Park HS, Kim GM. Kim CG, et al. Among authors: kim ij, kim si, kim gm, kim jh. J Breast Cancer. 2016 Mar;19(1):76-82. doi: 10.4048/jbc.2016.19.1.76. Epub 2016 Mar 25. J Breast Cancer. 2016. PMID: 27064666 Free PMC article.
Chemotherapy-induced irreversible alopecia in early breast cancer patients.
Kim GM, Kim S, Park HS, Kim JY, Nam S, Park S, Kim SI, Kim D, Sohn J. Kim GM, et al. Among authors: kim jy, kim d, kim s, kim si. Breast Cancer Res Treat. 2017 Jun;163(3):527-533. doi: 10.1007/s10549-017-4204-x. Epub 2017 Mar 21. Breast Cancer Res Treat. 2017. PMID: 28324267
Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients.
Park S, Koo JS, Kim GM, Sohn J, Kim SI, Cho YU, Park BW, Park VY, Yoon JH, Moon HJ, Kim MJ, Kim EK. Park S, et al. Among authors: kim gm, kim si, kim ek, kim mj. Cancer Res Treat. 2018 Jul;50(3):801-812. doi: 10.4143/crt.2017.210. Epub 2017 Aug 17. Cancer Res Treat. 2018. PMID: 28814071 Free PMC article.
CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator.
Moon YW, An HJ, Koo JS, Kim GM, Han H, Park S, Kim SI, Park HS, Kim S, Kim SK, Lee SA, Hwang S, Son GW, Sohn J. Moon YW, et al. Among authors: kim gm, kim si, kim s, kim sk. Oncotarget. 2017 Dec 21;9(2):2622-2630. doi: 10.18632/oncotarget.23519. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416796 Free PMC article.
Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study).
Kim JY, Im SA, Jung KH, Ro J, Sohn J, Kim JH, Park YH, Kim TY, Kim SB, Lee KS, Kim GM, Kim SH, Kim S, Ahn JS, Lee KH, Ahn JH, Park IH, Im YH; breast cancer committee of Korean Cancer Study Group (KCSG). Kim JY, et al. Among authors: kim sb, kim ty, kim sh, kim gm, kim s, kim jh. Eur J Cancer. 2018 Nov;103:127-136. doi: 10.1016/j.ejca.2018.08.004. Epub 2018 Sep 14. Eur J Cancer. 2018. PMID: 30223226 Clinical Trial.
607 results